CELYAD ONCOLOGY (CYAD.BR) Stock Analyst Ratings
Europe - Euronext Brussels - EBR:CYAD - BE0974260896 - Common Stock
0.2 EUR
0 (-1.96%)
ChartMill assigns a Buy % Consensus number of 42% to CYAD.BR. The Buy consensus is the weighted average rating of the current analysts ratings.
CYAD.BR was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about CYAD.BR.
In the previous month the buy percentage consensus was at a similar level.
CYAD.BR was analyzed by 9 analysts. More opinions would make the average more meaningful.
CELYAD ONCOLOGY / CYAD.BR FAQ
What is the consensus rating for CELYAD ONCOLOGY (CYAD.BR) stock?
The consensus rating for CELYAD ONCOLOGY (CYAD.BR) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.